What is Neureval?
Neureval operates at the intersection of neuroscience and digital innovation, providing a sophisticated platform dedicated to the interpretation of EEG brain wave patterns. The company serves a diverse ecosystem of stakeholders, including academic researchers, clinical healthcare professionals, and developers working on the next generation of brain-computer interface (BCI) technologies. By transforming raw neurological data into actionable insights, Neureval is effectively lowering the barrier to entry for high-fidelity brain activity analysis. Its market position is defined by a commitment to precision and accessibility, enabling users to integrate complex neuro-data into broader technological frameworks, thereby fostering advancements in both medical diagnostics and human-machine interaction.
How much funding has Neureval raised?
Neureval has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
Key Investors in Neureval
PPP
Public-Private Partnership
What's next for Neureval?
With the infusion of $17K, Neureval is strategically positioned to scale its operational infrastructure and expand its research capabilities. The current Series A/B growth stage suggests a focus on market penetration and the refinement of its proprietary algorithms to meet the increasing demand for reliable BCI solutions. Future initiatives will likely prioritize the enhancement of user experience for healthcare practitioners and the expansion of its developer-facing API suite. As the neurotech landscape matures, Neureval's ability to maintain data integrity while scaling its platform will be critical in securing a dominant share of the emerging brain-data analytics market.
See full Neureval company page
